title: Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Imasawa
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Ohshiro
authors.forename: Teruhiko
authors.initials: T
authors.lastname: Gotoh
authors.forename: Masahito
authors.initials: M
authors.lastname: Imai
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Iijima
mesh_terms: D001769:Blood; D002387:Cataract Extraction; D015862:Choroid Diseases / Q000139:chemically induced* / Q000175:diagnosis; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D017075:Laser Coagulation; D019654:Lens Implantation, Intraocular; D008269:Macular Edema / Q000188:drug therapy*; D008875:Middle Aged; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000009:adverse effects*; D014821:Vitrectomy
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide